comparemela.com

Latest Breaking News On - Enterprise pharmacy platform - Page 1 : comparemela.com

Capital Rx Debuts at No 33 on the 2022 Inc 5000 Annual List - With Three-Year Revenue Growth of 9894 84 Percent

/PRNewswire/ Today, Inc. revealed that Capital Rx is No. 33 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private.

Capital Rx Debuts at No 33 on the 2022 Inc 5000 Annual List - With Three-Year Revenue Growth of 9894 84 Percent

Capital Rx Debuts at No 33 on the 2022 Inc 5000 Annual List - With Three-Year Revenue Growth of 9894 84 Percent
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

EY Announces Capital Rx CEO and Co-Founder AJ Loiacono as an Entrepreneur Of The Year® 2022 New York Award Finalist

AlleyWatch - Page 2 of 946 - The Pulse of New York Tech

Capital Rx Secures $50 Million to Redefine Prescription Pricing

Capital Rx Secures $50 Million to Redefine Prescription Pricing What You Should Know: – Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today that it has raised $50 million in Series B financing. – Following the recent launch of JUDITM, the industry’s first Enterprise Pharmacy Platform, Capital Rx will continue to expand the platform’s capabilities, including leveraging AI to improve clinical care. Capital Rx, a New York City-based pharmacy benefit manager in the U.S., announced it has raised $50 million in Series B funding led by Transformational Capital, with participation from Edison Partners, who led Capital Rx’s Series A financing in 2019.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.